EVENTS
2024/10/24
250129ネットセミナー次世代ゼブラフィッシュ創薬の展開
2024/09/10
Zebrafish-Based Oncocardiology and Onconephrology
2024/07/05
新しいハイスループット個別ゼブラフィッシュ腎毒性スクリーニングシステムの創生と応用
2024/07/05
第51回日本毒性学会学術年会
》Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening
2021/10/13
BioJapan2021: Oct 13-15, 2021
We developed novel zebrafish model for patient-derived xenograft (PDXZ), and demonstrated that PDXZ has high rate and speed of engraftment in normal zebrafish when the immune system is immature, requires less than 100 cancer cells for transplantation, and can be quantitatively analyzed in 2 days. We report on drug efficacy screening system that can be quantitatively analyzed within a week.
関連リンク
関連ファイル
Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening